Optimising rotavirus vaccine effectiveness in Aboriginal children: a double blinded randomised trial of rotavirus vaccine given to infants 6 to 12 months old.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1086952

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Rotavirus is major cause of diarrhoeal illness in children. A vaccine to protect against rotavirus was introduced into Australia in 2006/7. Unfortunately vaccine protection is lowest in those in whom disease rates are highest, including Aboriginal infants in the Northern Territory. This trial will investigate if offering an additional dose of vaccine between 6 to 12 months is an effective way to improve vaccine protection and thereby reduce this disease disparity.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $2,333,318.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Aboriginal and Torres Strait Islander Health

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Aboriginal health | diarrhoeal disease | randomised controlled trial (RCT) | rotavirus infection | vaccine strategy

Related Links